Format

Send to

Choose Destination
Arch Virol. 1996;141(5):857-64.

Anti-EBNA1/anti-EBNA2 ratio decreases significantly in patients with progression of HIV infection.

Author information

1
Abteilung Innere Medizin IV, Universitätskliniken des Saarlandes, Homburg/Saar, Federal Republic of Germany.

Abstract

Reactivation of EBV infection is common in immunocompromised individuals. We determined specific antibodies to EBV-encoded nuclear antigens (EBNA)1 and 2 in 102 sera of HIV-infected individuals. Anti-EBNA1/anti-EBNA2 ratio (E1/E2) is less than 1 in chronic infection and exceeds 1 in healthy EBV-positive carriers. 52% of cases had E1/E2 < 1. E1/E2 decreased remarkably during the progression of HIV infection. Detectable HIV-Antigen, decline of CD4+ cell count and CD4+/CD8+ ratio were correlated with an increasing prevalence of E1/E2 below 1. We conclude that determination of E1/E2 is useful in immunocompromised patients.

PMID:
8678831
DOI:
10.1007/bf01718160
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center